McKinsey January 5, 2024
Neha Patel, Shubham Singhal

A new perspective on how technology, transformation efforts, and other changes have affected payers, health systems, healthcare services and technology, and pharmacy services.

The acute strain from labor shortages, inflation, and endemic COVID-19 on the healthcare industry’s financial health in 2022 is easing. Much of the improvement is the result of transformation efforts undertaken over the last year or two by healthcare delivery players, with healthcare payers acting more recently. Even so, health-system margins are lagging behind their financial performance relative to prepandemic levels. Skilled nursing and long-term-care profit pools continue to weaken. Eligibility redeterminations in a strong employment economy have hurt payers’ financial performance in the Medicaid segment. But Medicare Advantage and individual segment economics have held up well...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Biotechnology, Health System / Hospital, Insurance, Medicare Advantage, Payer, Pharma, Pharma / Biotech, Provider, Trends
GenAI is already transforming the healthcare industry
The Dawn Of Physical AI: Industry Leaders At SXSW Predict Its Impact
Q&A: Rural hospitals need help with cybersecurity survival
Radiology provider MedQuest part of deal to acquire 18 imaging centers from 1 of nation’s largest orthopedic groups
ASC block utilization by specialty

Share This Article